对接受标准间歇性预防性治疗(磺胺多辛-乙胺嘧啶)的孕妇开展社区疟疾筛查与治疗:一项多中心(冈比亚、布基纳法索和贝宁)整群随机对照试验
该多中心整群随机对照试验在冈比亚、布基纳法索和贝宁的村庄比较了社区健康工作者每月开展社区疟疾筛查与治疗(青蒿琥酯-苯芴醇)联合间歇性预防性治疗(IPTp-SP)与单独IPTp-SP对孕妇和婴儿健康的影响。结果显示,干预未降低胎盘疟疾(调整OR 1.06,95%CI 0.78-1.44,P=0.72),外周感染、贫血和不良妊娠结局也无差异;增加IPTp-SP剂量与胎盘疟疾、分娩时贫血和低出生体重风险降低显著相关。
要点
- 在IPTp-SP基础上增加社区疟疾筛查与治疗未降低胎盘疟疾风险(调整OR 1.06,95%CI 0.78-1.44,P=0.72)。
- 干预组与对照组在外周感染、贫血和不良妊娠结局方面无差异。
- 增加IPTp-SP剂量与胎盘疟疾、分娩时贫血和低出生体重风险显著降低相关。
核心结论
- 在现有IPTp-SP策略基础上增加社区疟疾筛查与治疗未减少妊娠期疟疾。
- 增加妊娠期IPTp-SP给药剂量是优先事项。
研究设计与样本
- 两臂整群随机对照试验,在布基纳法索、冈比亚和贝宁的村庄随机分配接受社区疟疾筛查与治疗联合IPTp-SP或单独IPTp-SP。
- 干预组社区健康工作者在妊娠期间每月进行社区疟疾筛查与治疗,每次接触采集滤纸和血涂片,分娩时采集胎盘活检。
主要发现
- 至少一次检测到疟疾感染的比例:冈比亚3.8%、贝宁16.9%、布基纳法索31.6%。
- 调整出生季节、产次和IPTp-SP剂量后,研究组间胎盘疟疾无差异(调整OR 1.06,95%CI 0.78-1.44,P=0.72)。
- 研究组间外周母体感染、贫血和不良妊娠结局无差异。
- 布基纳法索干预组产前门诊就诊率显著高于对照组,但冈比亚和贝宁无此差异。
- 增加IPTp-SP剂量与胎盘疟疾、分娩时贫血和低出生体重风险显著降低相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We investigated whether adding community scheduled malaria screening and treatment (CSST) with artemether-lumefantrine by community health workers (CHWs) to standard intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) would improve maternal and infant health. METHODS: In this 2-arm cluster-randomized, controlled trial, villages in Burkina Faso, The Gambia, and Benin were randomized to receive CSST plus IPTp-SP or IPTp-SP alone. CHWs in the intervention arm performed monthly CSST during pregnancy. At each contact, filter paper and blood slides were collected, and at delivery, a placental biopsy was collected. Primary and secondary endpoints were the prevalence of placental malaria, maternal anemia, maternal peripheral infection, low birth weight, antenatal clinic (ANC) attendance, and IPTp-SP coverage. RESULTS: Malaria infection was detected at least once for 3.8% women in The Gambia, 16.9% in Benin, and 31.6% in Burkina Faso. There was no difference between study arms in terms of placenta malaria after adjusting for birth season, parity, and IPTp-SP doses (adjusted odds ratio, 1.06 [95% confidence interval, .78-1.44]; P = .72). No difference between the study arms was found for peripheral maternal infection, anemia, and adverse pregnancy outcomes. ANC attendance was significantly higher in the intervention arm in Burkina Faso but not in The Gambia and Benin. Increasing number of IPTp-SP doses was associated with a significantly lower risk of placenta malaria, anemia at delivery, and low birth weight. CONCLUSIONS: Adding CSST to existing IPTp-SP strategies did not reduce malaria in pregnancy. Increasing the number of IPTp-SP doses given during pregnancy is a priority. CLINICAL TRIALS REGISTRATION: NCT01941264; ISRCTN37259296.
引用
- Community-based Malaria Screening and Treatment for Pregnant Women Receiving Standard Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: A Multicenter (The Gambia, Burkina Faso, and Benin) Cluster-randomized Controlled Trial. Clin Infect Dis. 2019. PMID: 29961848. doi:10.1093/cid/ciy522
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。